8K10Q · stockholder meetings · 1 October 2026

Where and when is the meeting?

Where, when and how a company meets its owners is a critical way to evaluate the company.

Coming up: every company’s next meeting

Redline: virtual

Loading the calendar…

For every company we show

WhenDate and time

WhereThe address, in the proxy’s words

In person?Can you walk in

Broadcast?Can everyone watch

Questions?Can anyone ask

How we mark it

Red markVirtual onlyNo room, no faces, no follow-up.

Red markAnother country, or hard to reachUS owners, overseas meeting.

Very positiveIn person + broadcast + open questionsOnly if they also meet in person.

Marks are 8K10Q’s opinion, drawn from the company’s filings. They are not investment advice.

First case: Theriva Biologics (TOVX)

Red mark · meetings moved to Spain

A Nevada company whose last US meeting was December 2025

Theriva’s 2024 annual meeting was at its offices in Rockville, Maryland. Since August 2025, five of its six meetings have been called for its research site in Parets del Vallès (Barcelona), Spain, at 3:30 p.m. local time. None of the proxies below offers a webcast or online attendance that we could find; to attend you must be there in person with photo ID.

Meeting	When	Where (the proxy’s words)	What happened
2024 annual	Oct 31, 2024, 9:30 a.m. ET	Offices of the Company, 9605 Medical Center Drive, Suite 270, Rockville, Maryland	Held; results filed (8-K, Nov 1 2024) Proxy
2025 annual	Aug 29, 2025, 3:30 p.m. local	Carrer Torrent de Can Ninou, naus 5-6, Parets del Vallès (Barcelona) Spain	Held; results filed (8-K, Sep 4 2025) Proxy
Special (warrants)	Dec 15, 2025, 9:00 a.m.	Principal office, 9605 Medical Center Drive, Suite 270, Rockville, Maryland	No quorum Proxy
Special (warrants)	Feb 11, 2026, 3:30 p.m. local	Parets del Vallès (Barcelona) Spain	No quorum Proxy
Special (warrants)	Apr 9, 2026, 3:30 p.m. local	Parets del Vallès (Barcelona) Spain	No quorum Proxy
Special (warrants)	Jun 5, 2026, 3:30 p.m. local	Parets del Vallès (Barcelona) Spain	No vote results filed Proxy
2026 annual	Aug 3, 2026, 3:30 p.m. local	Parets del Vallès (Barcelona) Spain	Held; the warrant exercise was approved here (Form 10-Q, Q2 2026). The ballot also asked to raise authorized shares to 450,000,000 (8-K, Aug 4 2026) Proxy

Sources: Theriva’s DEF 14A proxy statements and Item 5.07 8-Ks on SEC EDGAR, linked in each row. Quorum failures for the Dec 15, Feb 11 and Apr 9 meetings are stated in the company’s DEF 14A of April 30, 2026.

Can’t get there? We go for youAt cost: about $500–$700 US, $1,500–$2,000 overseas. We ask your questions. Going yourself?You’re in the 8K10Q Army if you attend.

Built 2026-10-01 · 8k10q meetings-1e